|
|
Article: African-Americans Respond Poorly to Hepatitis C Treatment.
- Article from:
- Ascribe Higher Education News Service
- Article date:
- May 26, 2004
CopyrightCOPYRIGHT 2004 AScribe. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: Duke University
DURHAM, N.C., May 26 (AScribe Newswire) -- African-Americans have a significantly lower response rate to treatment for chronic hepatitis C than non-Hispanic whites, according to a new study led by Duke University Medical Center researchers.
Some African-Americans -- 19 percent -- did respond to the drug combination of peginterferon alfa-2b and ribavirin. But in non-Hispanic whites with the same disease, the hepatitis C genotype 1 virus strain, 52 percent had no evidence of the virus in their blood six months after completing the drug therapy -- one of the highest response rates ever reported for this therapy. The study showed the ...